Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Pfizer 15.034, BioNTech 0.114.
Pfizer vs BioNTech: Revenue Comparison
Pfizer (PFE) and BioNTech (BNTX) are peers in Vaccines. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $114M for BioNTech. Pfizer leads on revenue.
Pfizer's gross margin is 72.8% versus 8.1% for BioNTech. Pfizer's net margin is -1.6% versus -777.3% for BioNTech.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, BioNTech.| Metric | Pfizer | BioNTech |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $114.00M |
| Cost of Revenue | $4.09B | $105.00M |
| Gross Profit | $10.94B | $9.00M |
| Operating Income | $4.71B | $-1.02B |
| Net Income | $-246.00M | $-886.00M |
| R&D Expense | $2.81B | $595.00M |
| Earnings Per Share | -$0.04 | -$3.5 |
| Gross Margin | 72.8% | 8.1% |
| Operating Margin | 31.3% | -897.8% |
| Net Profit Margin | -1.6% | -777.3% |
| Free Cash Flow | $302.00M | $-48.00M |
| Cumulative Free Cash Flow | $356.70B | $19.56B |
| Operating Cash Flow | $835.00M | $12.00M |
| Cash & Equivalents | $976.00M | $10.52B |